Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2020
Roche and Atea announce AT-527 collaboration
Roche and Atea Pharmaceuticals announced a collaboration to develop, manufacture, and distribute AT-527, an investigational oral antiviral being studied for COVID-19. Roche is responsible for distribution outside the United States; Atea is responsible for U.S. distribution, with an option to request Genentech’s support.